Welltower Inc logo

Welltower IncNYSE: WELL

Real Estate · Health Care REITs

$207.85

-2.65%

Vol: 2.6M

Research Digest

Wednesday, June 17, 2026

Neutral

No significant overnight updates

No material news in the last 48 hours.

Price 50d 200d

Previous Market Intelligence

13 days
Jun 16No significant overnight updatesNeutral

No material news in the last 48 hours.

Jun 15No significant overnight updatesNeutral

No material news in the last 48 hours.

Jun 14Welltower raised its dividend 15% and closed a $6.25B credit line, but shareholders rejected its say-on-pay vote.Mixed

Welltower announced a 15% increase in its quarterly common dividend to $0.85, effective Q2 2026, citing strong cash flow, and closed an amended $6.25 billion senior unsecured revolving credit line. However, shareholders rejected the company's say-on-pay proposal, raising governance and capital-allocation concerns, and the stock fell 3.54% on June 8. Welltower also announced a data-science partnership with Public Storage combining its capital-allocation models with Public Storage's pricing analytics. Recent results included strong Q1 earnings, raised full-year guidance, and analyst upgrades. The mix of a dividend hike and balance-sheet strength against a failed say-on-pay vote leaves a divided picture for the senior-housing REIT.

May 21Welltower raises 2026 FFO guidance after Q1 beat; multiple analysts hike targets to $238-$255 ahead of May 21 annual meeting.Positive

Welltower reported Q1 2026 FFO of $1.47/share, with revenue rising about 40%, senior housing same-store NOI up 23%, and portfolio occupancy improving to 88.8%. Same-store NOI grew 16.4%. Management raised full-year 2026 normalized FFO guidance while keeping payout ratio under 50%. Multiple analysts raised targets: Jefferies to $248 from $237 (May 12), Citi to $255 from $245 (May 5), BMO Capital to $245 from $240, RBC to $238 from $230, and UBS initiated coverage with a Buy and $249 target on May 4. The annual shareholder meeting is May 21, where shareholders vote on 9 directors and exec pay. The board declared a $0.74 quarterly dividend payable May 21. UK CMA found Welltower's £7B care home deals raise a 'realistic prospect' of substantial lessening of competition, moving the deal to in-depth investigation. Shares near $217.75 with 1-year total return of 46.98%.

May 20Welltower price target raised to $248 at Jefferies after historic Q1 senior housing NOI growth and raised 2026 guidance.Positive

Welltower posted blockbuster Q1 2026 results with normalized FFO of $1.47 per diluted share (+23% YoY) versus $1.44 estimate, and revenue surged 38.3% to roughly $3.35 billion. Same-store senior housing NOI grew 16.4% — the highest in company history — and the REIT raised full-year 2026 guidance. Investment activity remains aggressive: $3.2 billion across 41 transactions in Q1 (37 communities, 4,200+ units), totaling $10.5 billion for the year. The company is repositioning toward 85% senior housing concentration (from 60%) while reducing skilled nursing exposure. Jefferies raised its price target to $248 from $237 on May 13, and Citi lifted to $255 from $245. WELL has gained 45.5% over 52 weeks and 15.2% YTD with a Strong Buy consensus across 20 analysts. Risk: senior housing cyclicality and integration of large acquisitions.

May 19Welltower receives Jefferies price target hike to $248 ahead of May 21 annual meetingPositive

Welltower (WELL) saw Jefferies raise its price target to $248 from $237 on May 12, 2026, joining a wave of analyst upgrades following its strong Q1 2026 results showing normalized FFO of $1.47/share (up 23% YoY) and revenue surging 38.3% to $3.35B. The company raised its FY26 normalized FFO outlook to $6.21-$6.35 from $6.09-$6.25, citing 22.1% growth in Seniors Housing Operating. Welltower's annual shareholder meeting is scheduled for May 21, 2026 to elect nine directors and approve auditor and exec comp. The ex-dividend date is set for May 13, 2026. Risk: Strong Buy consensus from 20 analysts with mean $235.26 target. Other PT raises include Citi to $255, UBS to $249, BMO to $245, and RBC to $238.

May 18Welltower hosts annual shareholder meeting May 21 and pays $0.74 quarterly dividend May 21 as Jefferies lifts target to $248.Mixed

Welltower's virtual annual meeting is scheduled for May 21, where shareholders will vote on a nine-director slate, ratification of Ernst & Young as auditor for 2026, and an advisory vote on executive compensation. The $0.74 per share quarterly dividend goes to shareholders of record May 13 and pays May 21. Jefferies raised its price target to $248 from $237 on May 12, joining Citi ($255 from $245), BMO ($245 from $240), RBC ($238 from $230, Buy), and UBS ($249 from $240, Buy) in lifting targets following the strong Q1 print (revenue $3.35B, net income $728.67M, diluted EPS $1.02) and raised 2026 guidance ($3.24-$3.38 per diluted share). The UK Competition & Markets Authority concluded on May 7 that Welltower's 7 billion pound UK care-home transactions raise a 'realistic prospect' of substantial lessening of competition and signaled an in-depth investigation absent acceptable remedies.

May 15Jefferies raises Welltower price target to $248 on May 14 as senior housing momentum drives Q1 beat and raised guidancePositive

Jefferies lifted its price target on Welltower to $248 from $237 on May 14, the latest in a wave of upgrades following Q1 2026 results: revenue grew 38.3% YoY to ~$3.35B, FFO came in at $1.47 per share, and same-store NOI growth was 16.4% led by senior housing operating portfolio FFO up 23% and occupancy of 88.8%. The company raised 2026 net income guidance to $3.24-$3.38 per diluted share. Other recent actions: Citi to $255 (from $245), BMO to $245 (from $240), RBC to $238 (from $230, Buy reaffirmed), UBS to $249 (from $240). $0.74 quarterly dividend went ex on May 13, payable May 21. Annual meeting May 21 with 9 director elections and pay vote. Shares up 9.93% over the past 30 days.

May 14Jefferies raised Welltower's price target to $248 from $237 on May 11 following Q1 beat, raised 2026 guidance, and 16.4% same-store NOI growth.Mixed

Jefferies raised its PT to $248 (from $237) on May 11 as Welltower's Q1 2026 print delivered revenue of ~$3.35B (+38.3% YoY), diluted EPS of $1.02, and 16.4% same-store NOI growth in seniors housing, prompting raised full-year 2026 guidance. The board declared a $0.74/share dividend payable May 21 (ex-date May 13). Citi raised PT to $255 (May 5), with BMO ($245), RBC ($238) and UBS ($249) also raising. Why it matters: 30-day share return is +9.93% on momentum from operating outperformance and the Welltower 3.0 platform. Risk: the UK Competition & Markets Authority on May 7 concluded Welltower's £7B care-home transactions raise a 'realistic prospect' of substantial lessening of competition, moving the deals toward in-depth Phase 2 investigation absent acceptable remedies.

May 13Welltower Q1 2026 FFO of $1.47/share beat estimates with revenue up 38.3% to $3.35B; raised full-year guidance and multiple analysts hiked targets above $245.Positive

Welltower reported Q1 2026 FFO of $1.47 per share and revenue of $3.35B (+38.3% YoY), beating estimates and prompting a raise to full-year guidance. The company affirmed its dividend and highlighted progress on the Welltower 3.0 platform. A cash dividend of $0.74 was declared with ex-date May 13, 2026, payable May 21. Analyst price targets were raised in early May: Citi to $255, UBS to $249, BMO Capital to $245, RBC Capital to $238. Welltower and Public Storage announced a data science partnership combining capital allocation models with operational analytics. 30-day return is +9.93% with 1-year total return of +46.98%.

May 12BMO raised Welltower's PT to $245 on May 4 and Citi to $255 on May 5 after Q1 normalized FFO of $1.47 beat consensus and 2026 guidance was lifted.Positive

Welltower reported Q1 2026 normalized FFO of $1.47 (vs. $1.45 consensus) and revenue of $3.35B (vs. $3.2B expected), with same-store NOI growth of 16.4% and a low 2.73x net debt/adjusted EBITDA. The company raised its full-year 2026 guidance. BMO Capital raised its price target to $245 from $240 on May 4, RBC raised to $238 from $230, and Citi raised to $255 from $245 on May 5, all maintaining bullish ratings. Welltower posted a $0.74 quarterly dividend payable May 21 (record May 13) and holds its virtual annual shareholder meeting May 21. Shares have returned ~9.93% over the past 30 days.

May 11Welltower beat Q1 2026 estimates and raised full-year guidance, prompting multiple analyst price target hikes.Positive

Welltower reported Q1 2026 revenue of approximately $3.35 billion, net income of $728.67 million, and diluted EPS of $1.02, beating expectations. The company raised its full-year 2026 guidance, affirmed its dividend, and highlighted progress on its Welltower 3.0 platform with revenue and EBITDA surging over 35% YoY. Multiple analysts raised price targets in early May: Citi to $255 (from $245), BMO Capital to $245 (from $240), and RBC Capital to $238 (from $230). The board declared a quarterly cash dividend of $0.74 per share payable May 21, with the annual meeting scheduled the same day. Shares delivered 9.93% return in 30 days.

May 8Welltower raised 2026 guidance after Q1 beat with record 16.4% portfolio same-store NOI growth, BMO raised price target to $245.Positive

Welltower reported strong Q1 2026 results on May 4 with $1.47 normalized FFO per share and 38.3% revenue growth to $3.35 billion, beating expectations. The company raised its full-year 2026 net income guidance to $3.24-$3.38 per diluted share and reported record 16.4% portfolio same-store NOI growth, the highest in company history. SHOP portfolio delivered its 14th consecutive quarter of 20%+ same-store NOI growth. BMO Capital raised price target from $240 to $245 on May 4. Annual shareholder meeting scheduled May 21. Stock trades near $210 with 13 analysts rating Buy, average 12-month target $226.46.

Sector Peers

CompanyPriceDay1MFwd P/EBetaMkt Cap
WELLWELLTOWER$207.85-2.65%-5.3%61.5x0.78$145.8B
VTRVENTAS$82.55-1.60%-7.0%97.0x0.73$39.9B
DOCHEALTHPEAK$19.42-3.36%+0.5%129.3x1.03$13.4B
PLDPROLOGIS$141.21-3.36%-1.1%42.0x1.33$132.1B
EQIXEQUINIX$1,088.60-0.56%+3.8%56.6x0.97$107.4B
AMTAMERICAN$181.58-1.57%-1.0%26.2x0.89$84.4B

Key Fundamentals

Market Cap$145.8B
P/E (TTM)99.8
Forward P/E61.5
Beta0.78
Div Yield139.00%
Prev Close$213.50

RSI (14-Day)

36Neutral
0305070100

52-Week Range

$148.97$207.85$221.68
From High-6.2%
From Low+39.5%

Moving Averages

50d SMA
$208.15-0.1%
200d SMA
$189.81+9.5%

Price between 50d and 200d. Testing 50d support.

Historical Returns

1W
-4.7%
1M
+0.7%
3M
+0.3%
6M
+5.7%
1Y
+39.6%
YTD
+11.6%

Volume

Today2.6M
20d Avg2.6M
Ratio0.99x